Rajapakse Pramuditha
Department of Internal Medicine and Hematology/ Oncology, Danbury Hospital, Nuvance Health, 24, Hospital Ave., Danbury, CT 06810, USA. Email:
World J Oncol. 2021 Jun;12(2-3):45-49. doi: 10.14740/wjon1368. Epub 2021 May 14.
Recent advances in lung cancer therapeutics and screening have led to increased numbers of lung cancer survivors. Most survivors have undergone invasive treatment (surgery, radiation therapy, chemotherapy and/or immunotherapy) and carry a high comorbidity burden. Overall quality of life suffers during the evaluation, treatment and follow-up phase, with the potential for long-term decline. The issues faced by survivors include physical symptoms, emotional distress as well as socioeconomic instability. These issues may lead to poor compliance with recommended follow-up plan. This article provides an up-to-date literature review on the major issues faced by lung cancer survivors and identifies under-recognized problems such as stigma, financial toxicity and sexual dysfunction. Future collaborative efforts are needed to further elucidate the complex issues that affect overall well-being of lung cancer survivors and to develop appropriate interventions in this expanding survivor population.
肺癌治疗和筛查方面的最新进展使得肺癌幸存者数量增加。大多数幸存者都接受过侵入性治疗（手术、放射治疗、化疗和/或免疫治疗），且合并症负担较重。在评估、治疗和随访阶段，整体生活质量都会受到影响，并有长期下降的可能。幸存者面临的问题包括身体症状、情绪困扰以及社会经济不稳定。这些问题可能导致对推荐的随访计划依从性差。本文对肺癌幸存者面临的主要问题进行了最新的文献综述，并识别出一些未得到充分认识的问题，如耻辱感、经济毒性和性功能障碍。未来需要开展合作努力，以进一步阐明影响肺癌幸存者整体健康的复杂问题，并针对这一不断扩大的幸存者群体制定适当的干预措施。
